Summary:
- The article discusses the issue of clinical drug trials often excluding older adults, despite this population being the primary users of many medications.
- Researchers found that only 14% of participants in clinical trials for the top 200 prescribed drugs were 65 years or older, even though this age group accounts for over 30% of medication use.
- The exclusion of older adults from drug trials can lead to a lack of understanding about how medications may impact this population, potentially leading to safety concerns and suboptimal treatment.